MicrosoftTeams-image (5).png
Prostate Cancer Therapeutics Market Projected to Grow at 6.9% CAGR, Reaching USD 21.7 Billion by 2031: TMR Study
10 juil. 2023 05h30 HE | Transparency Market Research
Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer therapeutics market is projected to expand at a CAGR of 6.9% from 2022 to 2031 to reach US$ 21.7 Bn...
Contrive Datum Insights_Logo.jpg
Breast Cancer Market is Expected to Grow at a CAGR of 10.43%, Reaching a Valuation of US$ 70.51 Billion from 2022-2030, Contrive Datum Insights
25 janv. 2023 00h00 HE | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The global Breast Cancer Market size was estimated at USD 31.89 Billion in 2022 and is projected to hit around USD 70.51 Billion by 2030 with a...
MicrosoftTeams-image (5).png
Prostate Cancer Therapeutics Market to Expand at 6.9% CAGR during Forecast Period; Players Focus on Launching Effectual Therapies, States TMR Study
15 juil. 2022 10h30 HE | Transparency Market Research
Wilmington, Delaware, United States, July 15, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: According to the prostate cancer therapeutics market outlook by Transparency Market Research...
The American College
The American College of Rheumatology Recommends Biosimilar Use in New White Paper
07 févr. 2018 15h57 HE | American College of Rheumatology
Atlanta, Feb. 07, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) has published a new white paper, “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,”...